07:00 , Aug 20, 2012 |  BC Week In Review  |  Clinical News

CPAPP-A* test: Pivotal trial data

Beckman Coulter Inc. reported data from an analysis of 3,782 patients with non-ST-segment-elevation myocardial infarction (NSTEMI) ACS in the double-blind, placebo-controlled, international Phase III MERLIN-TIMI 36 trial of Ranexa ranolazine to treat ACS showing that...